Page 11 - Advaxis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pet Cancer Therapeutics Market Report Covers Future Trends with Research 2023–2031

StockNews.com began coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a report issued on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Ayala Pharmaceuticals Price Performance Shares of ADXS stock opened at $1.30 on Friday. Ayala Pharmaceuticals has a 12-month low of $1.00 and a 12-month high […]

StockNews.com began coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a report published on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Ayala Pharmaceuticals Stock Down 2.7 % OTCMKTS ADXS opened at $1.25 on Thursday. The business’s fifty day simple moving average is $1.50. Ayala Pharmaceuticals has a […]

Equities research analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report released on Monday. The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Price Performance About Ayala Pharmaceuticals (Get Rating) Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of […]

StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Ayala Pharmaceuticals Price Performance Shares of OTCMKTS:ADXS opened at $1.25 on Wednesday. The stock’s 50-day moving average is $1.50 and its 200 day moving average […]